Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Always Wellness and Recovery vs GoodRx

Always Wellness and Recovery
Graded #395

Lower grade

vs+12.099999999999994
GoodRx
Graded #116

Higher grade

The verdict

GoodRx takes it — 69.6/100 to 57.5/100.

GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGoodRx +35
45
80
Dose & formulationGoodRx +30
40
70
Clinical oversightAlways Wellness and Recovery +9
78
69
Labs & monitoringAlways Wellness and Recovery +14
65
51
FulfillmentGoodRx +14
67
81
Contract termsAlways Wellness and Recovery +6
61
55
Always Wellness and Recovery · left barGoodRx · right bar

The numbers

MetricAlways Wellness and RecoveryGoodRx
WeighScore57.5/10069.6/100
GradeCC
Scorecard rank#395#116
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosed$299/mo (brand Zepbound)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only

Strengths

  • Compounded semaglutide and tirzepatide with personalized dosing, not one-size-fits-all
  • No mandatory subscription — cancel anytime
  • Every case reviewed by a board-certified US physician (medical director Dr. M. Reyes, MD)
  • Unlimited HIPAA-secure messaging with the care team
  • Lab work included where clinically indicated; free discreet shipping in 3-5 days

Where it loses points

  • Pricing is not shown until you complete an application
  • Compounded GLP-1s are not FDA-approved finished products
  • No LegitScript certification visible and the compounding pharmacy is not named
  • Cash-pay only — no insurance billing
GoodRx

Graded #116 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard